154 related articles for article (PubMed ID: 34616632)
1. Multiomics-based analyses of KPNA2 highlight its multiple potentials in hepatocellular carcinoma.
Zhang J; Zhang X; Wang L; Kang C; Li N; Xiao Z; Dai L
PeerJ; 2021; 9():e12197. PubMed ID: 34616632
[TBL] [Abstract][Full Text] [Related]
2. KPNA2-Associated Immune Analyses Highlight the Dysregulation and Prognostic Effects of GRB2, NRAS, and Their RNA-Binding Proteins in Hepatocellular Carcinoma.
Zhang X; Zhang J; Gao F; Fan S; Dai L; Zhang J
Front Genet; 2020; 11():593273. PubMed ID: 33193737
[TBL] [Abstract][Full Text] [Related]
3. The role of KPNA2 as a monotonically changing differentially expressed gene in the diagnosis, risk stratification, and chemotherapy sensitivity of chronic hepatitis B-liver cirrhosis-hepatocellular carcinoma.
Pan Y; Zhang Y; Lu Z; Jin D; Li S
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13753-13771. PubMed ID: 37526663
[TBL] [Abstract][Full Text] [Related]
4. Upregulated KPNA2 promotes hepatocellular carcinoma progression and indicates prognostic significance across human cancer types.
Guo X; Wang Z; Zhang J; Xu Q; Hou G; Yang Y; Dong C; Liu G; Liang C; Liu L; Zhou W; Liu H
Acta Biochim Biophys Sin (Shanghai); 2019 Mar; 51(3):285-292. PubMed ID: 30883648
[TBL] [Abstract][Full Text] [Related]
5. Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer.
Drucker E; Holzer K; Pusch S; Winkler J; Calvisi DF; Eiteneuer E; Herpel E; Goeppert B; Roessler S; Ori A; Schirmacher P; Breuhahn K; Singer S
Cell Commun Signal; 2019 Nov; 17(1):159. PubMed ID: 31783876
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-139 inhibits hepatocellular carcinoma cell growth through down-regulating karyopherin alpha 2.
Zan Y; Wang B; Liang L; Deng Y; Tian T; Dai Z; Dong L
J Exp Clin Cancer Res; 2019 May; 38(1):182. PubMed ID: 31046781
[TBL] [Abstract][Full Text] [Related]
7. Karyopherin subunit-α 2 expression accelerates cell cycle progression by upregulating CCNB2 and CDK1 in hepatocellular carcinoma.
Gao CL; Wang GW; Yang GQ; Yang H; Zhuang L
Oncol Lett; 2018 Mar; 15(3):2815-2820. PubMed ID: 29435009
[TBL] [Abstract][Full Text] [Related]
8. Karyopherin alpha 2 expression is a novel diagnostic and prognostic factor for colorectal cancer.
Yu L; Wang G; Zhang Q; Gao L; Huang R; Chen Y; Tang Q; Liu J; Liu C; Wang H; Wang X
Oncol Lett; 2017 Mar; 13(3):1194-1200. PubMed ID: 28454233
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Karyopherin α2 in small cell carcinoma of the cervix correlates with poor prognosis.
Liao LM; Gu ZB; Fang M; Yao GJ; Huang L
Int J Clin Exp Pathol; 2022; 15(6):241-246. PubMed ID: 35795090
[TBL] [Abstract][Full Text] [Related]
10. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
11. CircMYH9 increases KPNA2 mRNA stability to promote hepatocellular carcinoma progression in an EIF4A3-dependent manner.
Xia J; Wu C; Tang Y; Tang J; Zhu D; Zhang F; Xu Z; Sun D; Tan Z; Zhuo H
Am J Cancer Res; 2022; 12(9):4361-4372. PubMed ID: 36225644
[TBL] [Abstract][Full Text] [Related]
12. Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear-Cell and Papillary Renal-Cell Carcinoma.
Müller T; Tolkach Y; Stahl D; Steiner S; Hauser S; Ellinger J; Rabien A; Ralla B; Jung K; Stephan C; Kristiansen G
Clin Genitourin Cancer; 2019 Feb; 17(1):e167-e175. PubMed ID: 30448104
[TBL] [Abstract][Full Text] [Related]
13. Construction of a Comprehensive Multiomics Map of Hepatocellular Carcinoma and Screening of Possible Driver Genes.
Liu Z; Lin Y; Gao X; Mai R; Piao X; Ye J; Liang R
Front Genet; 2020; 11():634. PubMed ID: 32670354
[No Abstract] [Full Text] [Related]
14. Identification of hub genes in hepatocellular carcinoma using integrated bioinformatic analysis.
Hua S; Ji Z; Quan Y; Zhan M; Wang H; Li W; Li Y; He X; Lu L
Aging (Albany NY); 2020 Mar; 12(6):5439-5468. PubMed ID: 32213663
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic KPNA2 Serves as a Biomarker and Immune Infiltration in Patients With HPV Positive Tongue Squamous Cell Carcinoma.
Gao L; Li Y; Yu C; Liu DX; Wu KH; Wei ZL; Liu MY; Yu L
Front Oncol; 2022; 12():847793. PubMed ID: 35860570
[TBL] [Abstract][Full Text] [Related]
16. Construction of a lipid metabolism-related and immune-associated prognostic signature for hepatocellular carcinoma.
Hu B; Yang XB; Sang XT
Cancer Med; 2020 Oct; 9(20):7646-7662. PubMed ID: 32813933
[TBL] [Abstract][Full Text] [Related]
17. A 4-gene prognostic signature predicting survival in hepatocellular carcinoma.
Chen PF; Li QH; Zeng LR; Yang XY; Peng PL; He JH; Fan B
J Cell Biochem; 2019 Jun; 120(6):9117-9124. PubMed ID: 30582205
[TBL] [Abstract][Full Text] [Related]
18. Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity.
Gluz O; Wild P; Meiler R; Diallo-Danebrock R; Ting E; Mohrmann S; Schuett G; Dahl E; Fuchs T; Herr A; Gaumann A; Frick M; Poremba C; Nitz UA; Hartmann A
Int J Cancer; 2008 Sep; 123(6):1433-8. PubMed ID: 18561322
[TBL] [Abstract][Full Text] [Related]
19. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma.
Zhu S; Huang X; Zhang K; Tan W; Lin Z; He Q; Chen Y; Shang C
Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731
[TBL] [Abstract][Full Text] [Related]
20. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
Ma C; Kang W; Yu L; Yang Z; Ding T
Front Oncol; 2020; 10():590006. PubMed ID: 33363020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
